I've tried kcl Infact I think half the people who post on here have probably tried but it only ever lands on stubborn deaf ears. Everything these guys release have zero accountability towards a timeline and a cash projection which means the business model communicated is utterly useless and impossible to provide any value to the investor. The anagrelide release the other day is just stupid . Why release all that info without any timeline or end game plan inclusive.
Have been trying to join some dots tonight...
if you want a laugh (cry) have a look at each of the 4Cs and the ....
9.1 Estimated Cash Outflows for next Quarter
they spend $250k consistently quarter after quarter on intellectual property but never once think to include this figure in the next quarters estimated cash outflows.
Quite funny how they missed the BP payment last month which caused uproar and an amended 4C but what about this omission? Unbelievable when it's around a $mil per Annum.
You can see why this companies share price and all their holders have been so bloody screwed over the past five years.
The best thing that's happened to this company in five years is the great myth that they invoice Strides circa $175k each month. No ones got any bloody idea if its true or otherwise . It really just sums up the whole bloody investment perfectly.
Perhaps things aren't anywhere near as bad as the share price and my post suggests but who would possibly know ?
SUD Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
